Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$252M |
| 2 |
Adobe
ADBE
|
+$238M |
| 3 |
Walmart Inc
WMT
|
+$233M |
| 4 |
Skyworks Solutions
SWKS
|
+$221M |
| 5 |
Target
TGT
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$361M |
| 2 |
Edison International
EIX
|
+$303M |
| 3 |
eBay
EBAY
|
+$281M |
| 4 |
Stellantis
STLA
|
+$276M |
| 5 |
Lam Research
LRCX
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.43% |
| 2 | Financials | 14.24% |
| 3 | Healthcare | 14.23% |
| 4 | Consumer Discretionary | 13.88% |
| 5 | Industrials | 12.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Microsoft
MSFT
$3.59T
| $1.36B | 1.47% |
14,903,017
+366,768
| +3% | +$33.5M |
|
2
Apple
AAPL
$4.51T
| $1.3B | 1.4% |
30,987,572
+428,264
| +1% | +$18.4M |
|
3
Meta Platforms (Facebook)
META
$1.4T
| $1.27B | 1.37% |
7,937,014
+1,025,998
| +15% | +$184M |
|
4
Amazon
AMZN
$2.79T
| $1.07B | 1.15% |
14,736,780
+2,281,360
| +18% | +$163M |
|
5
Micron Technology
MU
$1.09T
| $994M | 1.07% |
19,065,144
-402,515
| -2% | -$19.3M |
|
6
LyondellBasell Industries
LYB
$21.8B
| $974M | 1.05% |
9,212,193
-663,842
| -7% | -$74.2M |
|
|
7
Walmart Inc
WMT
$825B
| $914M | 0.99% |
30,836,190
+7,229,379
| +31% | +$233M |
|
8
JPMorgan Chase
JPM
$935B
| $882M | 0.95% |
8,021,897
+1,111,583
| +16% | +$126M |
|
|
RTN
9
DELISTED
Raytheon Company
RTN
| $865M | 0.93% |
4,007,725
+703,800
| +21% | +$146M |
|
10
Intel
INTC
$476B
| $859M | 0.93% |
16,494,472
+920,154
| +6% | +$43.7M |
|
11
Gilead Sciences
GILD
$181B
| $803M | 0.87% |
10,653,869
-1,978,920
| -16% | -$157M |
|
12
Allstate
ALL
$64.2B
| $773M | 0.83% |
8,124,497
+996,249
| +14% | +$96.5M |
|
13
Alphabet (Google) Class A
GOOGL
$4.22T
| $771M | 0.83% |
14,864,220
-2,092,000
| -12% | -$116M |
|
14
Oracle
ORCL
$422B
| $748M | 0.81% |
16,355,265
-336,305
| -2% | -$16.7M |
|
15
Western Digital
WDC
$166B
| $746M | 0.8% |
10,697,883
-3,448,830
| -24% | -$232M |
|
16
TSMC
TSM
$2.17T
| $738M | 0.8% |
16,869,049
+812,880
| +5% | +$35.4M |
|
17
Exelon
EXC
$45.1B
| $733M | 0.79% |
26,172,143
+4,893,866
| +23% | +$132M |
|
18
Humana
HUM
$45.5B
| $732M | 0.79% |
2,721,337
+89,212
| +3% | +$24.2M |
|
19
Johnson & Johnson
JNJ
$651B
| $700M | 0.75% |
5,462,381
+58,968
| +1% | +$7.97M |
|
20
Elevance Health
ELV
$86.9B
| $689M | 0.74% |
3,128,049
-327,075
| -9% | -$76.8M |
|
21
Alibaba
BABA
$286B
| $679M | 0.73% |
3,701,032
-193,919
| -5% | -$36.5M |
|
|
22
Boeing
BA
$169B
| $673M | 0.73% |
2,053,948
-1,069,435
| -34% | -$361M |
|
23
Biogen
BIIB
$32B
| $669M | 0.72% |
2,444,050
+477,916
| +24% | +$148M |
|
24
IBM
IBM
$222B
| $663M | 0.72% |
4,521,533
+211,556
| +5% | +$32M |
|
25
Aflac
AFL
$58.2B
| $641M | 0.69% |
14,650,378
+1,765,362
| +14% | +$78.1M |
|
Similar funds
Cliff Asness's Q1 2018 Portfolio in Review
As of Q1 2018, Cliff Asness held 2,349 positions worth $92.7B, down 2.7% from $95.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Cliff Asness's Q1 2018 filing shows 134 new, 942 increased, 1,022 reduced and 134 closed positions. Its largest new stake was Invesco QQQ Trust: 503,399 shares worth $74.4M. The largest sale was Boeing, an estimated $361M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
- Cliff Asness's largest Q1 2018 buy was Invesco QQQ Trust: 503,399 shares worth $74.4M.
- Cliff Asness added most to Estee Lauder in Q1 2018, an estimated $252M increase.
- Cliff Asness's biggest Q1 2018 reduction was Boeing, cutting an estimated $361M.
- Cliff Asness fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $94.9M.
- Cliff Asness's ten largest holdings make up 11% of its $92.7B portfolio in Q1 2018.
- Cliff Asness opened 134 new positions and closed 134 in Q1 2018.
- Cliff Asness's portfolio value fell 2.7% quarter-over-quarter to $92.7B.
Based on AQR Capital Management's 13F filing for Q1 2018, filed 15 May 2018.